Canadian Blood and Marrow Transplant Group
Cure Stems From Here
Clinical Trials Network
Clinical Trials Network
Background
Blood
and marrow transplantation (BMT) is playing an increasing role in the
management of patients with otherwise fatal diseases of the
hematopoietic and immune system and solid tumours. Currently, over 1200
transplants are performed annually by 23 Canadian programs, with the
number of transplants and transplant centres growing every year. New
technologies and management strategies for improving the success of BMT
are emerging rapidly from academic centres and industry; their
expeditious testing, timely dissemination of results and subsequent
implementation are mandatory to ensure the best care and risk
management for Canadians in need of a transplant.
While Canada's healthcare system offers a uniquely favourable environment for testing new therapies, relatively few large and decisive Canadian trials have been completed. While large-scale studies demand resources and patient participants very often beyond that which is available in a single Canadian centre, a network of cooperating centres would allow Canadians to conduct large and decisive studies in a timely manner. To this end, the CBMTG has established the Clinical Trials Network (CBMTG-CTN).
View the CTN Quarterly Report.
Mission
The mission of the CBMTG-CTN is:
to improve the safety, availability, and efficacy of hematopoietic stem cell transplantation for adults and children in Canada;
to perform clinical research trials that will define optimal hematopoietic stem cell transplantation for adults and children;
to conduct laboratory research that will translate into more effective treatments with reduced short and long-term side effects;
to build partnerships that will help fulfill the mission of the Canadian Blood and Marrow Transplant Group and improve the health of adults and children throughout the world.
Activities
Chaired by Dr. Ronan Foley, the
CBMTG Clinical Trials Network Committee (CTNC) governs the overall
activities of the Clinical Trials Network (CTN), including reviewing
and approving the research agenda, formulating and monitoring policies
and procedures, guiding research activities and overseeing
communications within the CTN and with the greater scientific community
and public. Research concept proposals are solicited, developed and
managed by Subcommittees of the CTNC.
Click on the relevant link below to view the structure and various activities of the CTNC:
Terms of Reference
Open Studies
Non-CBMTG Studies
Closed Studies
Concept Proposals
List of Publications
For more information about CBMTG Clinical Trials Open Studies, Concept Proposals or the CBMTG Clinical Trials Network, please contact Dr. Ronan Foley at foleyr@hhsc.ca or the CBMTG Head Office at cbmtg@malachite-mgmt.com.
You will need Adobe Acrobat Reader to view this document. A free download of the reader is available at the Adobe Website.
